Loading...
Global Bio-chem Technology Group Company Limited
GBCMY•PNK
Consumer Defensive
Packaged Foods
$0.49
$0.00(0.00%)
Global Bio-chem Technology Group Company Limited (GBCMY) Financial Performance & Income Statement Overview
Review Global Bio-chem Technology Group Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
45.65%
↑ 45.65%
Operating Income Growth
56.08%
↑ 56.08%
Net Income Growth
-81.78%
↓ 81.78%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
-11.06%
↓ 11.06%
Gross Margin
9.19%
↑ 9.19%
Net Profit Margin
256.63%
↑ 256.63%
ROE
-177.64%
↓ 177.64%
ROIC
9.16%
↑ 9.16%
Global Bio-chem Technology Group Company Limited (GBCMY) Income Statement & Financial Overview
Review Global Bio-chem Technology Group Company Limited's (GBCMY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.10B | $898.54M | $711.47M | $662.47M |
| Cost of Revenue | $949.90M | $832.52M | $629.60M | $700.70M |
| Gross Profit | $152.66M | $66.03M | $81.87M | -$38.23M |
| Gross Profit Ratio | $0.14 | $0.07 | $0.12 | -$0.06 |
| R&D Expenses | $4.13M | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $182.50M | $169.65M | $169.15M | $200.88M |
| Operating Expenses | $186.63M | $155.94M | $170.57M | $199.46M |
| Total Costs & Expenses | $1.14B | $988.45M | $800.17M | $900.16M |
| Interest Income | $0.00 | $186000.00 | -$135000.00 | $138000.00 |
| Interest Expense | $0.00 | $124.23M | $388.11M | $362.24M |
| Depreciation & Amortization | $155.81M | $135.41M | $78.47M | $163.34M |
| EBITDA | $47.83M | $101.90M | -$10.23M | $394.97M |
| EBITDA Ratio | $0.04 | $0.11 | -$0.01 | -$0.11 |
| Operating Income | -$33.97M | -$89.38M | -$88.70M | -$237.69M |
| Operating Income Ratio | -$0.03 | -$0.10 | -$0.12 | -$0.36 |
| Other Income/Expenses (Net) | $937.33M | -$68.36M | $3.92B | $107.08M |
| Income Before Tax | $903.36M | -$157.74M | $3.83B | -$130.61M |
| Income Before Tax Ratio | $0.82 | -$0.18 | $5.39 | -$0.20 |
| Income Tax Expense | $23.98M | $0.00 | -$6.60M | -$35.49M |
| Net Income | $927.34M | -$157.74M | $4.29B | -$64.90M |
| Net Income Ratio | $0.84 | -$0.18 | $6.03 | -$0.10 |
| EPS | $0.10 | -$0.02 | $0.48 | -$0.007 |
| Diluted EPS | $0.02 | -$0.02 | $0.48 | -$0.007 |
| Weighted Avg Shares Outstanding | $43.83B | $8.91B | $8.91B | $8.91B |
| Weighted Avg Shares Outstanding (Diluted) | $43.49B | $8.91B | $8.91B | $8.91B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan